Mimedx (MDXG) Change in Cash (2011 - 2026)

Mimedx has disclosed Change in Cash across 16 years of filings, most recently posting -$23.9 million for Q2 2026.

• In Q2 2026, Change in Cash fell 292.43% year-over-year to -$23.9 million; the TTM figure through Jun 2026 stood at $17.0 million (down 65.95% YoY), while the FY2025 annual figure was $61.7 million, up 175.27% from the prior year.
• Change in Cash came in at -$23.9 million for Q2 2026 at Mimedx, down from -$6.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $24.0 million in Q4 2025 to a low of -$33.5 million in Q1 2024.
• Average Change in Cash over 5 years is $2.7 million, with a median of $1.4 million recorded in 2023.
• Year-over-year, Change in Cash tumbled 1316.09% in 2022 and soared 1767.82% in 2024.
• Over 5 years, Change in Cash stood at -$7.3 million in 2022, then surged by 111.5% to $836000.0 in 2023, then soared by 1767.82% to $15.6 million in 2024, then soared by 53.94% to $24.0 million in 2025, then tumbled by 199.57% to -$23.9 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$23.9 million in Q2 2026, -$6.3 million in Q1 2026, and $24.0 million in Q4 2025.